Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection. (Q45377065)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 March 2010

Language	Label	Description	Also known as
English	Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.	scientific article published on 31 March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Sol Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ji-Eun Jang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jae-Rang Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

31 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

3801-3808

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Impact of respiratory virus infections on persons with chronic underlying conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Respiratory syncytial virus infection in older persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protection against respiratory syncytial virus infection by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Role of secretory antibodies in the defence against infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immunopathogenesis of vaccine-enhanced RSV disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Respiratory syncytial virus genetic and antigenic diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.03.032

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45377065&oldid=1382130840"